Psyence Biomedical Ltd. Approved to List on Nasdaq following

TORONTO, Jan. 25, 2024 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (“Psyence Biomed”) is excited to announce the completion of its merger (the “Business Combination”) with Newcourt Acquisition Corp ("Newcourt"), a

Related Keywords

United Kingdom , Toronto , Ontario , Canada , United States , Australia , Australian , Canadian , Commonwealth Of Australia , American , America , Neil Maresky , Psyence Biomed , Newcourt Acquisition Corp , Canadian Securities Exchange , Psyence Group , Nasdaq , Linkedin , Twitter , Pty Ltd , Instagram , Psyence Group Inc , Purpose Acquisition Company , Psyence Biomedical Ltd , Psyence Biomed Division , Business Combination , Note Financing , Special Meeting , Therapeutic Goods Administration , North America , Private Securities Litigation Reform Act , North American , Registration Statement , Psyence Production , Psyence Therapeutics , Psyence Function , Southern Africa , Acquisition Corp , Special Purpose Acquisition Company , Region ,